Planning & Evaluation Core

规划

基本信息

  • 批准号:
    10756838
  • 负责人:
  • 金额:
    $ 10.42万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-09-30 至 2028-08-31
  • 项目状态:
    未结题

项目摘要

ABSTRACT The Planning & Evaluation Core (P&E Core) of the Partnership for the Advancement of Cancer Research between New Mexico State University (NMSU) and Fred Hutchinson Cancer Center (Fred Hutch) coordinates critical functions necessary for the determination of the impact and effectiveness of Partnership activities in the attainment of its goals and objectives. P&E Core Leads, Dr. Rachel Boren at NMSU and Dr. Julian Simon at Fred Hutch have extensive expertise in program evaluation methodologies. Dr. Boren is Director of the Southwest Outreach Academic Research (SOAR) Evaluation and Policy Center at New Mexico State University and has been an evaluator for over 10 years. She has previously worked as an evaluator for the Institute of Translational Health Sciences (ITHS) based at the University of Washington. Fred Hutch is affiliated with the University of Washington and participates in the ITHS thus giving Dr. Boren a unique familiarity with both institutions. Dr. Simon has served as Research Project and Core Lead as well currently serving as MPI for the Partnership. His nearly 20-year involvement with the Partnership gives him a historical perspective on the culture of the collaboration. The five Specific Aims of the P&E Core are to: 1. Provide assessment tools to evaluate, track and report on progress in all aspects of the Partnership; 2. Release Requests for Applications for new pilot and full Research Projects and conduct rigorous review of proposals; 3. Engage community members and community action boards to evaluate impact of the Partnership on advancing regional cancer health equity; 4. Convene IAC and PSC to review progress of Cores and Research Projects, and facilitate communication between the advisory bodies, NCI and Core and Project Leads, and; 5. Evaluate the implementation and impact of the Guiding Principles (described in detail in Overall). In order to accomplish these Aims, the P&E Core will work with the MPIs (Drs. Graciela Unguez and Julian Simon) as well as Research Project and Core Leads to develop appropriate evaluation instruments to inform on the effectiveness of the Partnership’s activities. Quantitative and qualitative measure of outcomes will be collected and assessed based on the metrics described in the Logic Model (see P&E Core). New Research Projects will be solicited, evaluated, and implemented through the P&E Core. Current Research Projects and Cores will be evaluated and if necessary revised in consultation with the Internal Advisory Committee, the Program Steering Committee and NCI Program Staff. Rigorous review of the effectiveness of projects and activities will enable progress to meeting the Partnership’s goal of advancing health equity in the communities served.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Julian A Simon其他文献

Julian A Simon的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Julian A Simon', 18)}}的其他基金

Inhibition of B-Catenin Signaling for Treatment of Hepatocellular Carcinoma
抑制 B-连环蛋白信号转导治疗肝细胞癌
  • 批准号:
    8078972
  • 财政年份:
    2010
  • 资助金额:
    $ 10.42万
  • 项目类别:
Inhibition of B-Catenin Signaling for Treatment of Hepatocellular Carcinoma
抑制 B-连环蛋白信号转导治疗肝细胞癌
  • 批准号:
    7990951
  • 财政年份:
    2010
  • 资助金额:
    $ 10.42万
  • 项目类别:
Chemoprotection Against Aminoglycoside-Induced Ototoxicity
针对氨基糖苷类药物引起的耳毒性的化学保护
  • 批准号:
    8515203
  • 财政年份:
    2009
  • 资助金额:
    $ 10.42万
  • 项目类别:
Chemoprotection Against Aminoglycoside-Induced Ototoxicity
针对氨基糖苷类药物引起的耳毒性的化学保护
  • 批准号:
    7729834
  • 财政年份:
    2009
  • 资助金额:
    $ 10.42万
  • 项目类别:
Chemoprotection Against Aminoglycoside-Induced Ototoxicity
针对氨基糖苷类药物引起的耳毒性的化学保护
  • 批准号:
    8118073
  • 财政年份:
    2009
  • 资助金额:
    $ 10.42万
  • 项目类别:
Chemoprotection Against Aminoglycoside-Induced Ototoxicity
针对氨基糖苷类药物引起的耳毒性的化学保护
  • 批准号:
    8545455
  • 财政年份:
    2009
  • 资助金额:
    $ 10.42万
  • 项目类别:
Chemoprotection Against Aminoglycoside-Induced Ototoxicity
针对氨基糖苷类药物引起的耳毒性的化学保护
  • 批准号:
    7914280
  • 财政年份:
    2009
  • 资助金额:
    $ 10.42万
  • 项目类别:
Chemoprotection Against Aminoglycoside-Induced Ototoxicity
针对氨基糖苷类药物引起的耳毒性的化学保护
  • 批准号:
    8288091
  • 财政年份:
    2009
  • 资助金额:
    $ 10.42万
  • 项目类别:
Chemoprotection Against Aminoglycoside-Induced Ototoxicity
针对氨基糖苷类药物引起的耳毒性的化学保护
  • 批准号:
    8604242
  • 财政年份:
    2009
  • 资助金额:
    $ 10.42万
  • 项目类别:
Partnership for the Advancement of Cancer Research: NMSU-FHCRC (2 of 2)
促进癌症研究合作伙伴关系:NMSU-FHCRC(2 of 2)
  • 批准号:
    9342672
  • 财政年份:
    2007
  • 资助金额:
    $ 10.42万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 10.42万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.42万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 10.42万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.42万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 10.42万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 10.42万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.42万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 10.42万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 10.42万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.42万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了